|
|
||||||||
F508 cystic fibrosis mice, (b) whether adaptation to dietary salt depletion was preserved and (c) whether Cftrtm2cam
F508 mice exhibited enhanced amiloride-sensitive Na+ absorption.
F508 mice (0·47 ± 0·13 %, n = 7). Amiloride infusion significantly increased FENa in both wild-type (3·14 ± 0·83 %, n = 6) and Cftrtm2cam
F508 mice (3·47 ± 0·63 %, n = 9), though with no significant difference between genotypes.
F508 mice. No significant difference in the ability to adapt to low salt conditions was apparent comparing the two genotypes.
F508 mice (FENa = 1·97 ± 0·29 %, n = 9). The natriuresis induced by amiloride was significantly greater in Cftrtm2cam
F508 mice than in wild-type controls.
F508 mice exhibit normal renal salt excretion when either salt replete or salt restricted. Enhanced amiloride-sensitive FENa is consistent with increased Na+ absorption via the amiloride-sensitive sodium channel ENaC, in cystic fibrosis kidney, but this was only observed during salt restriction.
This article has been cited by other articles:
![]() |
O. Devuyst and W. B. Guggino Chloride channels in the kidney: lessons learned from knockout animals Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1176 - F1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-A. Konstas, J.-P. Koch, S. J. Tucker, and C. Korbmacher Cystic Fibrosis Transmembrane Conductance Regulator-dependent Up-regulation of Kir1.1 (ROMK) Renal K+ Channels by the Epithelial Sodium Channel J. Biol. Chem., July 5, 2002; 277(28): 25377 - 25384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. KIBBLE, A. NEAL, S. WHITE, R. GREEN, S. EVANS, and C. TAYLOR Renal Effects of Glibenclamide in Cystic Fibrosis Mice J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2507 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bens, J.-P. D. Van Huyen, F. Cluzeaud, J. Teulon, and A. Vandewalle CFTR disruption impairs cAMP-dependent Cl- secretion in primary cultures of mouse cortical collecting ducts Am J Physiol Renal Physiol, September 1, 2001; 281(3): F434 - F442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |